Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation Report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
At the meeting of the SNBTS directors, it was agreed that Professor Cash would write to the ACVSB asking that "careful consideration" be given to introducing a Hepatitis C lookback.
Published on:
05 August, 2024
A press release from Tom Sackville stated that "procedures have been established which make it possible to trace those at risk".
Published on:
05 August, 2024
A press release from Tom Sackville recorded that the Minister had asked Dr Metters, chair of the Advisory Committee and the Deputy CMO, to bring together an ad hoc working party of experts to draw up guidance on the procedure for undertaking lookback and for counselling those identified as being at risk, as well as guidance on the treatment options available.
Published on:
05 August, 2024
Professor Cash recommended that where a regular blood donor was confirmed as Hepatitis C positive "the fate of previous donations is determined and 'lookback' initiated in accordance with SNBTS policy."
Published on:
05 August, 2024
The outcome of the Hepatitis C lookback in England was formally reported. 50% of tested recipients were found to be infected with Hepatitis C. 4,432 recipients of 6,687 blood components were identified.
Published on:
05 August, 2024
The Scottish Office wrote to SNBTS asking them to take forward "as expeditiously as possible" a Hepatitis C lookback for all of Scotland and to keep the SHHD informed.
Published on:
05 August, 2024
The Standing Advisory Committee on Transfusion Transmitted Infections noted that "the issue needs resolution and will be examined in more detail by a group to be convened to consider it further."
Published on:
05 August, 2024
Dr Gunson and Dr Cash "agreed [that]...it would not, after we start anti-HCV donation screening, be appropriate to introduce a systematic look-back programme on previous recipient - as was done for HIV-1."
Published on:
05 August, 2024
Professor Cash, on behalf of SACTTI, produced a paper for the MSBT on the merits of adopting a Hepatitis C lookback policy. It stated that a Hepatitis C lookback could be based on the current procedures of HIV lookback.
Published on:
05 August, 2024
Dr Gunson of the National Blood Transfusion Service wrote to Professor Cash of the Scottish NBTS, advising him of discussions had at ACVSB and plans to table the subject in upcoming meetings, and the intention to ask John Craske for a copy of the questionnaire for counselling as compiled by Dr Julia Heptonstall.
Published on:
05 August, 2024
In a letter to Dr A Keel, Professor Franklin provided an update on the HCV lookback exercise, particularly the lack of funding needed to trace some patients, and considered the issue of RIBA indeterminates.
Published on:
05 August, 2024
In a letter to all doctors, Scottish Health Department CMO, Dr R E Kendell, provided guidance relating to the recently announced HCV lookback exercise and sought their assistance in identifying patients infected with HCV through blood transfusion.
Published on:
05 August, 2024
At a meeting of the SNBTS Medical & Scientific Committee It was recorded that "in the light of national events, it was agreed no 'Look Back' should be introduced at present."
Published on:
05 August, 2024
At a meeting of the Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation Dr Robinson presented a report on the HCV lookback.
Published on:
05 August, 2024
At a meeting of the Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation Dr Robinson presented the SACTTI's paper on Hepatitis C Lookback. Professor Arie Zuckerman raised concerns that interferon was not licensed for treatment of Hepatitis C-related disease and ribavirin was noted to be "even more costly."
Published on:
05 August, 2024
At a meeting, Dr Gillon briefed the SNBTS Medical and Scientific Committee on the Hepatitis C lookback.
Published on:
05 August, 2024
In a letter to Dr Gunson, Professor Cash proposed delaying any lookback programme until further UK deliberations had taken place.
Published on:
05 August, 2024
In a letter to Professor Cash, Dr Gunson noted the RTCs did not have access to anti-HCV testing material, and recommended usual investigations in reported cases involving a transfusion-associated NANBH.
Published on:
05 August, 2024
Dr Keel wrote to Professor Franklin to discuss the HCV lookback exercise in 1998, and noted it could not be considered formally closed until reasons for non-traceability of components or recipients were logged on the lookback register.
Published on:
05 August, 2024
Professor Cash wrote to Dr Jack Gillon to discuss the Medical & Scientific Committee agreement to use donor counselling guidelines in leaflet form within RTCs.
Published on:
05 August, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2197
Page
2198
Page
2199
Page
2200
Current page
2201
Page
2202
Page
2203
Page
2204
Page
2205
…
Next page
Next
Last page
Last